NFKB1 and B-cell chronic lymphocytic leukemia: More recently, it has been reported in chronic lymphocytic leukemia (CLL) that patient-derived T cells treated with the NAE inhibitor MLN4924 showed a differential expression of NF‐κB‐regulated genes and downregulated IL-2 expression/signaling during activation [49].